OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
Tatsuaki Watanabe, Tomoko Hosaka, Kaori Ohmori‐Matsuda, et al.
Health Science Reports (2018) Vol. 1, Iss. 6
Open Access | Times Cited: 12
Tatsuaki Watanabe, Tomoko Hosaka, Kaori Ohmori‐Matsuda, et al.
Health Science Reports (2018) Vol. 1, Iss. 6
Open Access | Times Cited: 12
Showing 12 citing articles:
RETRACTED ARTICLE: Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1
Zhenming Jiang, Yuxi Zhang, Xi Chen, et al.
Gene Therapy (2019) Vol. 27, Iss. 3-4, pp. 143-156
Closed Access | Times Cited: 26
Zhenming Jiang, Yuxi Zhang, Xi Chen, et al.
Gene Therapy (2019) Vol. 27, Iss. 3-4, pp. 143-156
Closed Access | Times Cited: 26
Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
Suyan Xu, Hongyan Zhang, Aifeng Wang, et al.
Cellular & Molecular Biology Letters (2020) Vol. 25, Iss. 1
Open Access | Times Cited: 24
Suyan Xu, Hongyan Zhang, Aifeng Wang, et al.
Cellular & Molecular Biology Letters (2020) Vol. 25, Iss. 1
Open Access | Times Cited: 24
<p>MiR-216b suppresses cell proliferation, migration, invasion, and epithelial–mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer</p>
Lidong Wang, Yansen Wang, Xiangyang Du, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 2999-3009
Open Access | Times Cited: 20
Lidong Wang, Yansen Wang, Xiangyang Du, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 2999-3009
Open Access | Times Cited: 20
Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma
Miho Yamamoto, Soji Ozawa, Yamato Ninomiya, et al.
Esophagus (2020) Vol. 17, Iss. 3, pp. 289-297
Closed Access | Times Cited: 19
Miho Yamamoto, Soji Ozawa, Yamato Ninomiya, et al.
Esophagus (2020) Vol. 17, Iss. 3, pp. 289-297
Closed Access | Times Cited: 19
Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification
Yirizhati Aili, Nuersimanguli Maimaitiming, Aierpati Maimaiti, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-25
Open Access | Times Cited: 2
Yirizhati Aili, Nuersimanguli Maimaitiming, Aierpati Maimaiti, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-25
Open Access | Times Cited: 2
Comprehensive Analysis to Identify the Vasohibin1 (VASH1) Emerges as a Novel Prognosis Biomarker in High-Risk Low-Grade Glioma
Yirizhati Aili, Aierpati Maimaiti, Nuersimanguli Maimaitiming, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Yirizhati Aili, Aierpati Maimaiti, Nuersimanguli Maimaitiming, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Clinical and prognostic role of Vasohibin-1 expression in solid tumors: An evidence from a meta-analysis
Ye Tian, Chenkui Miao, Xiaohan Ren, et al.
Research Square (Research Square) (2020)
Open Access
Ye Tian, Chenkui Miao, Xiaohan Ren, et al.
Research Square (Research Square) (2020)
Open Access
Clinical and Prognostic Role of Vasohibin-1 Expression in Solid Tumors
Ye Tian, Chenkui Miao, Xiaohan Ren, et al.
Research Square (Research Square) (2020)
Open Access
Ye Tian, Chenkui Miao, Xiaohan Ren, et al.
Research Square (Research Square) (2020)
Open Access
Assessment of the Concentration of Endogenous Factors Regulating Angiogenesis, VASH-1 and VEGF-A, in the Blood Serum of Patients with Neuroendocrine Neoplasms
Janusz Strzelczyk, Monika Wójcik-Giertuga, Piotr Cuber, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-8
Open Access
Janusz Strzelczyk, Monika Wójcik-Giertuga, Piotr Cuber, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-8
Open Access
Determining the Vasohibin-1 Levels of the Serum and Broncoalveolar Lavage Fluid in the Patients with Lung Cancer”
Alev Lazoğlu Özkaya, Mevlüt Sait Keleş, Esra Laloğlu, et al.
Konuralp Tıp Dergisi (2022) Vol. 14, Iss. 2, pp. 298-303
Open Access
Alev Lazoğlu Özkaya, Mevlüt Sait Keleş, Esra Laloğlu, et al.
Konuralp Tıp Dergisi (2022) Vol. 14, Iss. 2, pp. 298-303
Open Access
Significance of vasohibin 1 in cancer patients: A systematic review and meta analysis
Shuai Liu, Bing Han, Meili Sun, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 2, pp. 567-575
Open Access
Shuai Liu, Bing Han, Meili Sun, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 2, pp. 567-575
Open Access
